Evidence map›Paper›PMID 30442134›Full record

ArticleMalaria journal2018

Levels of human proteins in plasma associated with acute paediatric malaria.

Philippa Reuterswärd, Sofia Bergström, Judy Orikiiriza, Elisabeth Lindquist, Sven Bergström, Helene Andersson Svahn, Burcu Ayoglu, Mathias Uhlén, Mats Wahlgren, Johan Normark and 2 more

Open access · goldAbstract read
In one paragraph

Article in Malaria journal, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 2 pooled it
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 2 syntheses or guidelines pooled it, 22 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 3 countries.

Philippa ReuterswärdDepartment of Protein Science, SciLifeLab, KTH Royal Institute of Technology, Stockholm, Sweden. philippa.reutersward@scilifelab.se.ORCID http://orcid.org/0000-0003-0344-8049
Sofia BergströmDepartment of Protein Science, SciLifeLab, KTH Royal Institute of Technology, Stockholm, Sweden.
Judy OrikiirizaInfectious Diseases Institute, College of Health Sciences, Makerere University, Kampala, Uganda.
Elisabeth LindquistDepartment of Molecular Biology, Umeå University, Umeå, Sweden.
Sven BergströmDepartment of Molecular Biology, Umeå University, Umeå, Sweden.
Helene Andersson SvahnDepartment of Protein Science, SciLifeLab, KTH Royal Institute of Technology, Stockholm, Sweden.
Burcu AyogluDepartment of Protein Science, SciLifeLab, KTH Royal Institute of Technology, Stockholm, Sweden.
Mathias UhlénDepartment of Protein Science, SciLifeLab, KTH Royal Institute of Technology, Stockholm, Sweden.
Mats WahlgrenDepartment of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden.
Johan NormarkDepartment of Molecular Biology, Umeå University, Umeå, Sweden.
Ulf RibackeDepartment of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden.
Peter NilssonDepartment of Protein Science, SciLifeLab, KTH Royal Institute of Technology, Stockholm, Sweden.
Science for Life Laboratory · SEKarolinska Institutet · SEUmeå University · SEInfectious Diseases Institute · UG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe intimate interaction between the pathophysiology of the human host and the biology of the Plasmodium falciparum parasite results in a wide spectrum of disease outcomes in malaria. Development of severe disease is associated with a progressively augmented imbalance in pro- and anti-inflammatory responses to high parasite loads and sequestration of parasitized erythrocytes. Although these phenomena collectively constitute common denominators for the wide variety of discrete severe malaria manifestations, the mechanistic rationales behind discrepancies in outcome are poorly understood. Exploration of the human pathophysiological response by variations in protein profiles in plasma presents an excellent opportunity to increase the understanding. This is ultimately required for better prediction, prevention and treatment of malaria, which is essential for ongoing elimination and eradication efforts.

resultsAn affinity proteomics approach was used to analyse 541 paediatric plasma samples collected from community controls and patients with mild or severe malaria in Rwanda. Protein profiles were generated with an antibody-based suspension bead array containing 255 antibodies targetting 115 human proteins. Here, 57 proteins were identified with significantly altered levels (adjusted p-values < 0.001) in patients with malaria compared to controls. From these, the 27 most significant proteins (adjusted p-values < 10

conclusionIn this study, a high-throughput affinity proteomics approach was used to find protein profiles in plasma linked to P. falciparum infection and malaria disease progression. The proteins presented herein are mainly involved in inflammatory response, cellular adhesion and as constituents of erythrocyte membrane. These findings have a great potential to provide increased conceptual understanding of host-parasite interaction and malaria pathogenesis.

Indexed as

Host-Parasite InteractionsBlood ProteinsCell AdhesionChildChild, PreschoolErythrocytesFemaleHumansInfantInflammationMalariaMalaria, FalciparumMalePlasmodium falciparumRwandaBlood ProteinsAffinity proteomicsCytoadhesionHuman plasma profilingMalariaPlasmodium falciparum, suspension bead arraysSequestration

Identifiers

PMID30442134
PMCPMC6238294
OpenAlexW2900556057

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.